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Improvement of Lipid Absorption in Young Pigs as a Model for
Preterm Infants
A. S. Leaflet R1958
Carnagey, K. M.1, D. S. Lewis2, J. W. Stewart3, and D. C.
Beitz1
1Dept. Animal Science, Iowa State University, Ames, IA,
2Dept Human Nutrition and Food Science, Cal Poly
Pomona, Pomona, CA, 3Dept. Food Science and Human
Nutrition, Iowa State University, Ames, IA
Summary and Implications
Preterm infants and neonatal suckling piglets have a
limited bile acid pool that may hinder absorption of dietary
lipids such as fatty acids, triacylglycerols (TAGs), and other
lipid-soluble nutrients.  Because dietary lipids are a valuable
source of energy for growth, it is important that they are
efficiently absorbed.  The hypothesis of this study is that
oral administration of 0.2 g/kg body weight daily of
cholylsarcosine, an artificial bile acid, would decrease fecal
excretion of dietary fatty acids and TAGs in suckling
piglets.  Twelve 7-d-old piglets were housed individually
and fed a commercial milk replacer with or without oral
cholylsarcosine until 21 d of age.  Cholylsarcosine treatment
decreased fecal excretion of stearic acid (18:0) and palmitic
acid (16:0) (P ≤ 0.02).  Cholylsarcosine supplementation
had no effect on absorption of unsaturated fatty acids of 16
or 18 carbons (P > 0.05).  Cholylsarcosine increased fecal
excretion of deoxycholic acid (P = 0.03).  Apparent
absorption of dietary TAGs was increased from 77% in
piglets not fed cholylsarcosine to 83% in the piglets that
received oral cholylsarcosine.  These results support the
hypothesis that cholylsarcosine increases absorption of
dietary TAGs.
Introduction
Preterm human infants have low lipid absorption during
the first few weeks of life.  Contributing factors include
inadequate amounts of lipolytic enzymes, high percentage
of long-chain and saturated fatty acids in milk, incomplete
development of the digestive tract, and the small bile acid
pool.  Long-chain fatty acids are hydrolyzed more poorly
from milk TAGs for absorption than are short- or medium-
chain fatty acids, and saturated fatty acids are hydrolyzed
more poorly from milk TAGs for absorption than are
unsaturated fatty acids.  In addition, a relatively small bile
acid pool likely limits the absorption of dietary fatty acids in
preterm human infants.
Neonatal piglets have been used as a model for studies
of pediatric growth, nutrition, and metabolism for many
years.  Neonatal piglets are similar to human preterm infants
in their size, organ structure, and nutritional needs.
Neonatal piglets exhibit many of the same limitations of
lipid digestion and absorption as do preterm human infants.
The bile acid pool in very young, suckling pigs is small on a
per weight basis compared with that in weaned pigs.
Additionally, lipid absorption in neonatal piglets depends on
the type of dietary fatty acid and the development of the
digestive tract.  Like preterm human infants, researchers
have noted that piglets do not efficiently absorb long-chain
saturated fatty acids.  Approximately 40% of fatty acids in
human milk are saturated.  These saturated fatty acids,
palmitic acid and stearic acid in particular, are not
emulsified or hydrolyzed efficiently from TAGs for
absorption by piglets.  As a result of these similarities, the
suckling neonatal piglet is useful as a model for the study of
lipid absorption in preterm human infants.
Bile acids, which are essential to the emulsification and
absorption of fatty acids and other lipid-soluble nutrients
from the diet, are synthesized in liver and stored in the
gallbladder.  Bile acid release from the gallbladder into the
small intestine is stimulated in response to eating.  Bile
acids act as detergents to emulsify lipids.   Lipids must be
emulsified before they can be broken apart and absorbed.
Bile acid concentration in preterm human infants and in
neonatal piglets is very low compared with that of adults of
the same species.  This low bile acid concentration is likely
to cause low dietary lipid absorption because dietary lipids
are not emulsified, and, therefore, breakdown and
absorption of fatty acids from dietary lipids  occurs more
poorly than is needed for optimal growth.
The hypothesis is that oral cholylsarcosine, a
synthetically conjugated bile acid, will increase the
efficiency of dietary fat absorption in neonatal piglets.
Improved absorption efficiency during the suckling period is
expected to result in increased energy available for growth
of neonatal piglets, thereby increasing rate of gain. To test
this hypothesis, fecal excretion of fatty and bile acids by
suckling piglets with or without cholylsarcosine
supplementation in their diet was evaluated.
Materials and Methods
Experimental Design
Animal use for this study was approved by the
Committee of Animal Care at Iowa State University.
Twelve 5-d-old crossbred (Duroc x Hampshire x Yorkshire)
female piglets were obtained from the Iowa State University
Swine Research Center.  Piglets were weighed and placed in
metabolism cages in groups of 3 for 2 d to allow for
adjustment to metabolism cages and for time for piglets to
learn how to use the feeders.  After 2 d, piglets were
weighed and placed in individual metabolism cages.  Piglets
were assigned randomly to a treatment: control (formula
only) or cholylsarcosine (0.2 g/kg body weight
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cholylsarcosine divided equally and fed twice daily with the
formula).  All piglets were fed ad libitum Piglet Liquwean®
milk replacement formula (Milk Specialties, Inc., Dundee,
IL).  The diet contained 25% protein, 13% total fat, 43%
lactose, 0.15% fiber, and 9.8% ash, with the remaining
percentage being composed of minerals, extra amino acids,
and antibiotics on a dry-matter basis.  The fatty acid
composition was 3.2% 14:0, 26.6% 16:0, 3% 16:1, 13.5%
18:0, 43% 18:1, and 11% 18:2.
Chemical Analyses
Fecal samples were weighed, freeze-dried, and
reweighed to determine dry matter content.  Freeze-dried
samples were ground by using a mortar and pestle and then
stored in desiccators until analyzed for lipid and bile acid
composition and for lipid class composition.  Total lipid
content of the feces as well as fatty acid composition of the
TAG and of free fatty acid fractions and bile acid
composition of feces were determined.
Statistical Analyses
To determine differences between treatment groups and
ages of piglets, all data on the excretion of fatty and bile
acids were analyzed by using the Proc Mixed procedure in
SAS version 8.0 (The SAS Institute, Cary, NC) to
accurately analyze the repeated measures in this experiment.
The LSMeans procedure also was used to obtain means and
standard errors for fatty and bile acids as well as percentage
enrichments by stable isotopes.  Because two of the piglets
became ill, n equaled 10.  Significance was declared when P
< 0.05.  When P < 0.10, a tendency for groups to differ was
declared.
Results
On average, all piglets consumed approximately 1100
kcal digestible energy daly, which closely matches the NRC
recommendation.  Piglets receiving cholylsarcosine were
expected to have an increased rate of gain when compared
with those that did not receive cholylsarcosine because
cholylsarcosine should increase available dietary energy for
growth.  Contrary to predictions, rate of gain in piglets fed
cholylsarcosine was similar to that of controls (P > 0.05)
(Table 1).  Likewise, there was no effect of cholylsarcosine
on feed intake (P > 0.05).
To determine whether bile acid status of piglets limited
fatty acid absorption from dietary TAG, the effect of
supplemental cholylsarcosine on fecal excretion of fatty
acids was determined.  Apparent absorption of dietary TAG
in suckling piglets supplemented with cholylsarcosine was
approximately 83%.  In suckling piglets fed formula alone
(control), apparent absorption was approximately 77%.
Fecal output was similar for the two groups.
Cholylsarcosine, however, did influence absorption of
specific dietary fatty acids.  Fecal excretion of palmitic and
stearic acids was decreased by oral administration of
cholylsarcosine (P ≤ 0.02) (Table 2).  Excretion of
unsaturated fatty acids of 16 and 18 carbons showed little
change as expected as they are efficiently hydrolyzed and
absorbed in nearly all neonates.  Excretion of all 16 carbon
fatty acids and stearic acid decreased as the age of the
suckling piglets increased (P < 0.05).  Excretion of
unsaturated 18 carbon fatty acids tended to decrease (P =
0.07) as age of the suckling piglets increased.  There was no
interaction between age and treatment effects.
Discussion
Cholylsarcosine increases the apparent absorption of
dietary fatty acids in neonatal piglets by about 6%; however,
this increase did not translate to increased gain or gain:feed.
The maximal increase in growth that can be expected from a
6% increase in lipid absorption is 2.3 g body weight per day
given the formula these piglets were fed.  Considering this
fact, it is not surprising that the difference in growth over
the 14-d period was not significant.  Fecal excretion of
saturated fatty acids was decreased by treatment with oral
cholylsarcosine (Table 2), which is in accordance with other
studies that show that, when emulsifiers were added to the
diet or when vegetable oils or short-chain fatty acids were
fed to suckling or early-weaned piglets, lipid digestibility
was improved.   The decrease in fatty acid excretion caused
by supplementation with dietary cholylsarcosine also agrees
with studies that show cholylsarcosine decreases fatty acid
excretion in humans with compromised bowel function.
Evidently, the supplemented cholylsarcosine enhanced the
emulsification of dietary TAGs, thereby facilitating the
absorption of greater amounts of dietary TAGs.  It is
possible that, by feeding a diet with a higher concentration
of saturated fatty acids, greater differences in absorption
might have become evident, resulting in an improvemetn in
growth data.
Conclusion
Bile acids probably are one of the limiting factors in
lipid absorption in neonatal piglets.  Results from this study
indicate that the addition of an orally administered model
bile acid improves saturated fatty acid absorption.  No
change in growth, however, was observed.  A longer-term
study or a study with more piglets seems necessary to
determine if cholylsarcosine increases the growth rate of
neonatal piglets.  Our results indicate that is seems feasible
to supplement preterm human infants with cholylsarcosine
to improve absorption of dietary TAGs and lipid-soluble
nutrients.  At least, the findings support a clinical trial with
humans to test the effects of cholylsarcosine on fatty acid
excretion in preterm infants.
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Table 1.  Daily formula intake, growth, and fecal excretion of suckling piglets from 7 to 21 days of age.
a Not significant.
b Growth over 14 d.
c Average daily gain (g)/average daily intake on dry matter basis (g).
n = 10
Table 2.  Effect of cholylsarcosine and increasing age on the excretion of fatty acids by suckling piglets.
a  Mean ± standard error expressed as µmoles fatty acid/g dry feces.
b Average daily change was calculated by the difference between the concentrations of bile acids excreted
on consecutive days for pigs in both groups.  Values are expressed as µmoles/g • d dry feces.
P-value indicates differences in fatty acid excretion: Treatment: Between cholylsarcosine and control
groups.  Age: As a function of increasing age of piglets.
n = 10
Cholylsarcosine Control P-value
Total Gain (kg)b 4.31 4.21 NSa
Average Daily Gain (g/d)b 308 301 NS
Intake (L/d) 1.41 1.42 NS
Feed Efficiencyc 1.22 1.18 NS
Fecal Output (g) 65.02 72.42 NS
P-Value
Fatty Acid Cholylsarcosine Control
Average Daily
Change Treatment Age
16:1 0.937 ±0.17a 1.004 ± 0.19 -2.826b 0.71 0.05
16:0 46.757 ± 2.14 55.534 ± 2.41 -0.149 0.02 0.0001
18:1,2,3 10.833 ± 0.94 10.602 ± 1.06 -0.643 0.85 0.07
18:0 51.330 ± 1.94 65.296 ± 4.24 -0.869 0.003 0.02
